Atlas Trials

The Effect Tenofovir Disoproxil Fumarate (TDF) and Tenofovir Alafenamide (TAF) on Small Intestine Gut Wall

Clinical trial NCT05326971 · UNKNOWN

Trial details

NCT number
NCT05326971
Sponsor
Jussi Sutinen
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionsWeight Gain
Start date
2023-01-19
Primary completion
2025-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.